The now multibillion dollar industry just in the Columbus area has had a presence in the region for the last decade.

Legend Biotech Corporation (NASDAQ:LEGN) is one of the most promising future stocks according to Wall Street analysts. On August 12, RBC Capital raised the firm’s price target on Legend Biotech Corporation (NASDAQ:LEGN) to $77 from $75,

The first half of 2025 was brutal for biotech, but investors are still keen on therapeutics in several indications and silver linings exist, particularly for private companies.  | The first half of 2025 was brutal for biotech,

Biotech investors tend to focus on small-cap companies in search of the next big breakthrough. Still, one established player is quietly strengthening its pipeline in ways that the market has yet to fully recognize.

I maintain a Strong Buy on Krystal Biotech, as the pause in melanoma trial enrollment is offset by promising progress in inhaled KB707 for NSCLC. Inhaled KB707 achieved a 36% ORR in heavily pretreated NSCLC patients, and an FDA end-of-Phase-2 meeting is scheduled for October 2025.

The U.S. government announced funding cuts to mRNA vaccine research. What is the impact on American healthcare and biotech?

RALEIGH, N.C. (WTVD) -- With so much uncertainty in the job market, along with concerns about funding for higher education, Wake Tech is actually experiencing explosive growth. The school's president is optimistic about the future at the largest community college in North Carolina.

Biotech stock Halozyme Therapeutics rallies to an all-time high on Thursday. Shares are in a buy zone above a buy point of 70.51.